The Patent Finder
AN

Agendia N.V.

First filing 2009
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Four patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Dec 2031. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Dec 2031
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2015 to 2042.
US 10,036,070 Methods and Means for Molecular Classification of Colorectal Cancers Dec 23, 2031
US 9,175,351 Means and Methods for Molecular Classification of Breast Cancer Aug 2, 2032
US 10,072,301 Means and Methods for Molecular Classification of Breast Cancer Aug 2, 2032
US 11,954,859 Methods of Assessing Diseases Using Image Classifiers Sep 20, 2042
20212027203320392042
6 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 3, 2027
    The maintenance fee for Means and Methods for Molecular Classification of Breast Cancer (US 9,175,351) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
  • 1 fee due Oct 9, 2027
    The maintenance fee for Methods of Assessing Diseases Using Image Classifiers (US 11,954,859) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 4 of 4

PatentTitleStatusExpiresConfidence
US 10,036,070Methods and Means for Molecular Classification of Colorectal Cancers
In force
 · High confidence
In forceHigh confidence
US 9,175,351Means and Methods for Molecular Classification of Breast Cancer
In force
 · High confidence
In forceHigh confidence
US 10,072,301Means and Methods for Molecular Classification of Breast Cancer
In force
 · High confidence
In forceHigh confidence
US 11,954,859Methods of Assessing Diseases Using Image Classifiers
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 3 patents ended · 6 applications pending · 13 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited